These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8678824)

  • 1. Drug treatment in the perinatal period and the risk of functional teratogenicity.
    Benesová O
    Arch Toxicol Suppl; 1996; 18():89-96. PubMed ID: 8678824
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuro-immuno-teratogenicity of drugs used in neonatal pharmacotherapy in relation to the ontogenic stage at the time of their administration.
    Benesová O; Tejkalová H; Kristofiková Z; Panajotova V; Husek P
    Gen Physiol Biophys; 1999 Oct; 18 Spec No():21-7. PubMed ID: 10703715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
    Ornoy A
    Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of the teratogenic risk of drugs administered in the perinatal period].
    Benesová O; Pavlík A
    Cas Lek Cesk; 1988 Jan; 127(5):149-52. PubMed ID: 3356033
    [No Abstract]   [Full Text] [Related]  

  • 5. Methods of evaluating the alleged teratogenicity of environmental agents.
    Brent RL
    Prog Clin Biol Res; 1985; 163C():191-5. PubMed ID: 3991621
    [No Abstract]   [Full Text] [Related]  

  • 6. Levamisole (Decaris) treatment during pregnancy.
    Kazy Z; Puhó E; Czeizel AE
    Reprod Toxicol; 2004 Nov; 19(1):3. PubMed ID: 15336707
    [No Abstract]   [Full Text] [Related]  

  • 7. Skeletal malformations and variations in developmental toxicity studies: interpretation issues for human risk assessment.
    Daston GP; Seed J
    Birth Defects Res B Dev Reprod Toxicol; 2007 Dec; 80(6):421-4. PubMed ID: 18157902
    [No Abstract]   [Full Text] [Related]  

  • 8. Azathioprine teratogenicity: review of the literature and case report.
    Gebhardt DO
    Obstet Gynecol; 1983 Feb; 61(2):270. PubMed ID: 6823371
    [No Abstract]   [Full Text] [Related]  

  • 9. [A genetically defined model for testing teratogenicity in vivo].
    Oksa A; Spálová I
    Sb Lek; 1988 Jun; 90(6):161-6. PubMed ID: 3261883
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural changes of placenta following maternal administration of acetaldehyde in rat.
    Sreenathan RN; Padmanabhan R; Singh S
    Z Mikrosk Anat Forsch; 1984; 98(4):597-604. PubMed ID: 6524011
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Teratogenicity analyzed.
    Milkovich L; van den Berg BJ
    N Engl J Med; 1975 Aug; 293(6):307-8. PubMed ID: 1138189
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk minimization practices for pregnancy prevention: understanding risk, selecting tools.
    Uhl K; Trontell A; Kennedy D
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):337-48. PubMed ID: 16953517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Perinatal care in France: is the Swedish model possible?].
    Sizun J; Casper C; Ratynski N; Gremmo-Feger G
    Arch Pediatr; 2010 Oct; 17(10):1391-3. PubMed ID: 20724122
    [No Abstract]   [Full Text] [Related]  

  • 14. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing.
    Webster WS; Brown-Woodman PD; Ritchie HE
    Int J Dev Biol; 1997 Apr; 41(2):329-35. PubMed ID: 9184342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach.
    Nava-Ocampo AA; Koren G
    Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropharmacology of drugs and alcohol in mother and fetus.
    Pollard I
    Semin Fetal Neonatal Med; 2007 Apr; 12(2):106-13. PubMed ID: 17240208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal health care in Japan.
    Nishida H
    J Perinatol; 1997; 17(1):70-4. PubMed ID: 9069070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical issues in perinatal medicine: Indian perspective.
    Singh M
    Indian Pediatr; 1995 Sep; 32(9):953-8. PubMed ID: 8935257
    [No Abstract]   [Full Text] [Related]  

  • 19. Monitoring and avoiding drug and chemical teratogenicity.
    Koren G; MacLeod SM
    CMAJ; 1986 Nov; 135(10):1079-81. PubMed ID: 3094926
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of teratogenic action of thalidomide.
    Vaisman B
    Teratology; 1996 May; 53(5):283-4. PubMed ID: 8879085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.